✦ LIBER ✦

Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study

✍ Scribed by Dodick, David W; Goadsby, Peter J; Spierings, Egilius L H; Scherer, Joel C; Sweeney, Steven P; Grayzel, David S

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and efficacy of the peptide-based

✍ Pollard, Richard B; Rockstroh, Jürgen K; Pantaleo, Giuseppe; Asmuth, David M; Pe 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 458 KB

Efficacy, safety, and tolerability of a

✍ Michael J Koren; Rob Scott; Jae B Kim; Beat Knusel; Thomas Liu; Lei Lei; Michael 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 384 KB

Efficacy and safety of ustekinumab, a hu

✍ Kim A Papp; Richard G Langley; Mark Lebwohl; Gerald G Krueger; Philippe Szapary; 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 295 KB

Efficacy and tolerability of MK-0974 (te

✍ Tony W Ho; Michel D Ferrari; David W Dodick; Vince Galet; James Kost; Xiaoyin Fa 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 177 KB

Efficacy and safety of itolizumab, a nov

✍ Krupashankar, D.S.; Dogra, Sunil; Kura, Mahendra; Saraswat, Abir; Budamakuntla, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 694 KB

929a A Phase 2, Randomized, Double-blind

✍ Lembo, Anthony; Camilleri, Michael; McCallum, Richard W.; Sastre, Ramon F.; Bret 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 170 KB